Sales of Novo Nordisk's Wegovy and Eli Lilly's Mounjaro in India doubled in July, according to Pharmarack data. Wegovy, ...

Hyderabad: Pharma giant Eli Lilly and Company (India) opened its new technology and innovation centre in Hyderabad's Hitech ...

Hyderabad: Eli Lilly and Company (India) has announced the opening of its new technology and innovation site in Hyderabad; a ...

Hyderabad: Ina major boost to Telangana’s life sciences and innovation ecosystem, global pharmaceutical giant Eli Lilly ...

Lilly expands India presence with inauguration of Hyderabad site to accelerate global digital innovation: Our Bureau, Mumbai ...

Eli Lilly and Company opens new technology and innovation site in Hyderabad, India to enhance global operations.

Eli Lilly and Company has opened a technology and innovation center in, India. This strategic hub, covering 2.2 lakh sqft, ...

Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm Pharmarack showed on Monday.

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...

FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, are seen in a fridge at a health clinic in Hyderabad, India, April 14, 2025.

HYDERABAD, Feb 28 (Reuters) - U.S. drugmaker Eli Lilly (LLY.N) expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after ...